ANNA HUNG-CHAN: Open Payments
NPI 1881064004 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,767 in 177 payments from 17 companies in 2025. Trend: 2023 $512 · 2024 $0 · 2025 $2,767
Food & beverage: $2,767
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 30 | $445 |
| ABBVIE INC. | 32 | $376 |
| Otsuka America Pharmaceutical, Inc. | 21 | $363 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $346 |
| Teva Pharmaceuticals USA, Inc. | 19 | $304 |
| Axsome Therapeutics, Inc. | 22 | $256 |
| Neurocrine BioSciences, Inc. | 4 | $184 |
| Vanda Pharmaceuticals Inc. | 9 | $173 |
| Lundbeck LLC | 5 | $90 |
| Alkermes, Inc. | 4 | $66 |
Products named: COBENFY, VRAYLAR, CAPLYTA, REXULTI, Auvelity, AUSTEDO XR, INGREZZA, FANAPT.
Industry payments across OH — which companies pay providers there.
